DiscoverExecutive Insights for Life Sciences InnovatorsMark Stead | Atomic AI – Harnessing Artificial Intelligence and Structural Biology to Unlock RNA Therapeutics
Mark Stead | Atomic AI – Harnessing Artificial Intelligence and Structural Biology to Unlock RNA Therapeutics

Mark Stead | Atomic AI – Harnessing Artificial Intelligence and Structural Biology to Unlock RNA Therapeutics

Update: 2025-09-05
Share

Description

In this episode of Executive Insights for Life Sciences Innovators, we speak with Mark Stead of Atomic AI, a biotech harnessing artificial intelligence and structural biology to unlock RNA’s therapeutic potential. Mark shares how Atomic AI is building a discovery platform to model RNA structures with unprecedented accuracy, opening the door to new classes of medicines for oncology, rare diseases, and beyond.

Learn more at genecoda.com.

Originally recorded and streamed on YouTube Live on August 22, 2025.

Comments 
In Channel
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Mark Stead | Atomic AI – Harnessing Artificial Intelligence and Structural Biology to Unlock RNA Therapeutics

Mark Stead | Atomic AI – Harnessing Artificial Intelligence and Structural Biology to Unlock RNA Therapeutics

GeneCoda® Executive Search